Motivating Occupational Virtual Experiences In Therapy for kids

激发儿童治疗中的职业虚拟体验

• 批准号: 10264174
• 负责人: Richard J. Adams
• 金额: $ 92.8万
• 依托单位: BARRON ASSOCIATES, INC.
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-04-01 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10264174
• 关键词: Address; Adherence; Affect; Award; Blinded; Brain Injuries; Cerebral Palsy; Child; Childhood; Childhood stroke; Clinical; Clinical Research; Clinical Trials; Computer software; Development; Disease; Elements; Evidence based treatment; Exercise; Goals; Gold; Hand functions; Healthcare; Hemiplegia; Home; Human; Improve Access; Intervention; Interview; Learning; Marketing; Measures; Medical; Modeling; Monitor; Motion; Motivation; Motor; Motor Skills; Movement; Neuronal Plasticity; Occupational; Outcome; Parents; Participant; Patient Participation; Patients; Pediatric Hospitals; Performance; Phase; Pilot Projects; Play; Production; Provider; Public Health; Questionnaires; Randomized Controlled Trials; Recovery; Regimen; Rehabilitation therapy; Role playing therapy; Safety; Secure; Self Care; Small Business Innovation Research Grant; Specialist; Supervision; Support System; System; Technology; Testing; Toy; Training; Trauma; Universities; Upper Extremity; User-Computer Interface; Video Games; Virginia; Visual; base; cohort; commercialization; compliance behavior; constraint induced movement therapy; constraint induced therapy; cost; cost effective; dashboard; data fusion; design; dosage; efficacy study; evidence base; exercise program; experience; haptic feedback; improved; improved outcome; individual patient; individualized medicine; innovation; innovative technologies; kinematics; mixed reality; multisensory; programs; prototype; psychologic; remote monitoring; sensor; skills; standard measure; success; telehealth; therapy adherence; therapy duration; treatment as usual; treatment group; tumor; underserved area; usability; virtual; virtual world

PROJECT SUMMARY/ABSTRACT Introduction: The Motivating Occupational Virtual Experiences In Therapy for kids (MOVE-IT) SBIR Phase II program will support telehealth delivery of intensive rehabilitation for pediatric hemiplegia through smart toy- enabled games that inspire high-dosage, task-directed upper extremity (UE) movements. Although higher- dosage training is almost uniformly associated with better outcomes in UE rehabilitation [1], [2], [3], [4], achieving the repetitions necessary to attain lasting results through neuroplasticity is a formidable challenge. The MOVE- IT system will employ therapy games that combine virtual- and real-world physical elements to provide a turn- key solution suitable for both home and clinical use. MOVE-IT will engage patients in repetitive practice, facilitating an evidence-based approach that integrates proven concepts in constraint-induced movement therapy (CIMT) and other intensive therapy regimes [5]. This innovative solution employs a multi-sensory smart toy, advanced game engine, and low-cost motion tracking to create games that promote sustained adherence. Problem to be Addressed: Pediatric hemiplegia can result from Cerebral Palsy (CP) or acquired brain injury (including pediatric stroke, trauma, tumor, or other disease), and adversely affect motor functions essential to self-care, play, exploratory learning, and other daily activities [6]. Existing systems do not currently support telehealth delivery of the high-dosage, evidence-based therapy required for improvement in UE function. Long-Term Goals: Provide an effective home exercise program supported by remote guidance and monitoring of evidence-based treatment for pediatric hemiplegia. Improve patient participation and adherence to an intensive therapy regimen. Reduce the cost of, and improve access to, state-of-the-art rehabilitation. Provide validated metrics for remotely tracking patient status and progress. Phase I Results: Phase I produced a prototype smart toy, two UE therapy mini-games, human kinematics tracking software, and validated UE motor performance metrics. A pilot study was conducted at the University of Virginia (UVA) Children’s Hospital involving 10 children with hemiplegia. Analysis confirms the primary Phase I hypothesis that MOVE-IT generated metrics have high criterion validity with gold-standard measures of UE motor function. Patient/parent interviews/questionnaires strongly support the technology’s acceptance and usability. Phase II Summary: MOVE-IT Phase II will produce a commercial system including an enhanced smart toy and quest-based game software for sustained engagement over a full course of therapy; demonstrate efficacy; establish safety and usability; and pursue FDA-clearance. Phase II will culminate in a rater-blinded randomized, controlled trial to investigate efficacy in home use by children with hemiplegia, as measured by change in gold- standard measures of UE function for a cohort using MOVE-IT compared to a usual care treatment (UCT) group. Commercial Opportunity: High likelihood of commercialization is supported by Barron Associates’ past successes in development, clinical trials, FDA-clearance, and marketing of innovative technology for UE therapy.

项目概要/摘要 简介：儿童治疗中的激励性职业虚拟体验 (MOVE-IT) SBIR 第二阶段 该计划将通过智能玩具支持小儿偏瘫强化康复的远程医疗服务 激发高剂量、任务导向的上肢（UE）运动的游戏。 训练几乎一致与 UE 康复中更好的剂量结果相关 [1]、[2]、[3]、[4]， 通过神经可塑性获得持久结果所需的重复是一项艰巨的挑战。 IT系统将采用结合虚拟和现实世界物理元素的治疗游戏来提供回合制治疗。 适合家庭和临床使用的关键解决方案将让患者进行重复练习， 促进基于证据的方法，将经过验证的概念整合到约束引起的运动中 治疗 (CIMT) 和其他强化治疗方案 [5] 这种创新的解决方案采用了多感官智能。 玩具、先进的游戏引擎和低成本的运动跟踪来创建促进持续坚持的游戏。 要解决的问题：小儿偏瘫可能是由脑瘫（CP）或后天性脑损伤引起的 （包括小儿中风、创伤、肿瘤或其他疾病），并对运动至关重要的功能产生不利影响 自我护理、玩耍、探索性学习和其他日常活动目前不支持[6]。 远程医疗提供改善 UE 功能所需的高剂量、循证治疗。 长期目标：提供由远程指导和监控支持的有效家庭锻炼计划 提高小儿偏瘫循证治疗的参与度和依从性。 强化治疗方案。降低最先进康复治疗的成本并改善其获得机会。 用于远程跟踪患者状态和进展的经过验证的指标。 一期成果：一期生产出一款智能玩具原型、两款UE治疗小游戏、人体运动学 跟踪软件，并验证了 UE 运动性能指标 在大学进行了一项试点研究。 弗吉尼亚州 (UVA) 儿童医院对 10 名偏瘫儿童进行的分析证实了第一阶段的研究结果。 假设 MOVE-IT 生成的指标对于 UE 电机的黄金标准测量具有高标准有效性 患者/家长访谈/问卷调查强烈支持该技术的接受度和可用性。 第二阶段总结：MOVE-IT 第二阶段将生产一个商业系统，包括增强型智能玩具和 基于任务的游戏软件，可在整个治疗过程中持续参与，展示疗效； 确定安全性和可用性；并寻求 FDA 批准，最终将进行评估者盲法随机、 对照试验调查偏瘫儿童在家使用的效果，通过金-变化来衡量 使用 MOVE-IT 的队列与常规护理治疗 (UCT) 组相比，UE 功能的标准测量。 商业机会：Barron Associates 过去的经验支持商业化的可能性很高 UE 疗法创新技术的开发、临床试验、FDA 批准和营销方面取得了成功。